SKIN logo

SkinHealth Systems Inc. Stock Price

NasdaqCM:SKIN Community·US$117.9m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

SKIN Share Price Performance

US$0.91
-0.96 (-51.36%)
US$1.34
Fair Value
US$0.91
-0.96 (-51.36%)
32.2% undervalued intrinsic discount
US$1.34
Fair Value
Price US$0.91
AnalystConsensusTarget US$1.34
AnalystHighTarget US$2.00
AnalystLowTarget US$1.00

SKIN Community Narratives

·
Fair Value US$1.34 32.2% undervalued intrinsic discount

Premium Beauty Markets Will Face Risks And Rewards

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
·
Fair Value US$2 54.5% undervalued intrinsic discount

Rising Self-Care And Telehealth Trends Will Power Global Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$1 9.0% undervalued intrinsic discount

Less Invasive Aesthetic Demand Will Support Consumables While Device Weakness Keeps Expectations Grounded

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

Updated Narratives

SKIN logo

SKIN: Fair Outlook Weighs Competitive Pressure Against New FDA Clearances

Fair Value: US$1 9.0% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SKIN logo

SKIN: Clearer Device Positioning And Margins Will Support Future Upside

Fair Value: US$2 54.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SKIN logo

SKIN: Future Returns Will Hinge On Delivering FY26 EBITDA Under Competitive Pressure

Fair Value: US$1.34 32.2% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and fair value.

2 Risks
2 Rewards

SkinHealth Systems Inc. Key Details

US$296.1m

Revenue

US$103.9m

Cost of Revenue

US$192.2m

Gross Profit

US$198.8m

Other Expenses

-US$6.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.05
64.91%
-2.21%
623.1%
View Full Analysis

About SKIN

Founded
1997
Employees
613
CEO
Pedro Malha
WebsiteView website
www.skinhealthsystems.com

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Recent SKIN News & Updates

Narrative Update Jul 10

SKIN: Fair Outlook Weighs Competitive Pressure Against New FDA Clearances

Analysts have trimmed their price target on SkinHealth Systems to $1.00 from $1.50, citing updated assumptions that reflect softer modeled revenue growth, a lower fair value estimate, modestly improved profit margin expectations, and a reduced future P/E multiple in light of ongoing competitive pressures in the lower end of the market. Analyst Commentary on SkinHealth Systems Recent research commentary on SkinHealth Systems points to a more cautious stance, with several bearish analysts revisiting their models after the latest quarterly update and trimming valuation assumptions to reflect ongoing competitive and execution risks.
Narrative Update Jun 26

SKIN: Clearer Device Positioning And Margins Will Support Future Upside

Analysts have reduced the SkinHealth Systems price target to $2.00 from $3.50, citing updated models that reflect higher discount rates, softer revenue growth assumptions, lower expected profit margins, and a much higher projected future P/E multiple in light of rising competitive pressures across the beauty device market. Analyst Commentary Recent Street research on SkinHealth Systems highlights that analysts are recalibrating their expectations while still pointing to potential areas where the stock could regain investor interest.

Recent updates

No updates